Mobidiag Signs Multiple International Agreements for Distribution of Its Amplidiag® and Novodiag® Diagnostic Solutions
Kort samengevat
ESPOO, Finland--(BUSINESS WIRE)--Feb 25, 2019--Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today announces that it has signed multiple exclusive agreements with international partners for the distribution of its Amplidiag ® and N
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Associated Press.
Lees het volledige bericht ↗